… We aim to investigate the risk factors that may predict the BRAF V600E mutation potential
of … A total of 9,908 papillary thyroid carcinoma patients with average 74.6% BRAF V600E …

… BRAF V600E mutation was associated with an increased recurrence rate of papillary thyroid
carcinoma … -analysis to assess the impact of the BRAF V600E mutation on PTC recurrences. …

… of extra-thyroid disease, we did not demonstrate any association of BRAF gene mutation …
High quality data on the effect of BRAF gene mutation on vascular invasion is lacking in the …

… of the thyroid gland is papillary thyroid carcinoma (PTC). The … %) is a missense mutation
in the BRAF oncogene, valine (V) … of the MAPK pathway, either BRAF-like and RAS-like [5]. …

… BRAF V600E, through overactivating the … that BRAF V600E might play an important role in
LNM-related mortality risk in PTC, thus differentiating LNM in wild-type BRAF PTC and BRAF-…

… BRAF-mutant PTCs from the TCGA Thyroid Cancer (THCA) study (15). We defined 2 subgroups
of BRAF … relatively preserved expression of thyroid differentiation genes (BRAF-TDS hi ; …

… Thyroid cancer primarily includes the following four pathological … : papillary thyroid carcinoma,
follicular thyroid carcinoma, undifferentiated carcinoma and medullary thyroid carcinoma. …

… Understanding how BRAF pathway stimulates … that BRAF V600E promotes thyroid cancer
development by increasing myeloid-derived suppressor cells (MDSCs) penetrance. This BRAF …

… Background: BRAF V600E and TERT promoter alterations … for precision management of
papillary thyroid cancer. It remains … genomic DNA from papillary thyroid cancer in 608 patients (…

… Papillary thyroid cancer organoids harboring BRAF V600E mutation reveal potentially
beneficial effects of BRAF … Papillary thyroid cancer (PTC), which is often driven by acquired …